JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

JNJ

229.64

+0.81%↑

UNH

369.73

+0.08%↑

TMO

476.34

+1.91%↑

ISRG

454.78

+0.68%↑

ABT

90.61

-1.86%↓

Search

Inspire Medical Systems Inc

Abierto

SectorSanidad

53.15 -0.99

Resumen

Variación precio

24h

Actual

Mínimo

52.37

Máximo

53.67

Métricas clave

By Trading Economics

Ingresos

126M

136M

Ventas

45M

269M

P/B

Media del Sector

11.262

67.147

Margen de beneficios

50.577

Empleados

1,333

EBITDA

33M

50M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+22.9% upside

Dividendos

By Dow Jones

Próximas Ganancias

4 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-376M

1.6B

Apertura anterior

54.14

Cierre anterior

53.15

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

201 / 348 Clasificación en Healthcare

Inspire Medical Systems Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 abr 2026, 23:53 UTC

Ganancias

Naver Posts Weaker First-Quarter Earnings

29 abr 2026, 23:41 UTC

Acciones populares

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29 abr 2026, 23:55 UTC

Ganancias

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29 abr 2026, 23:54 UTC

Ganancias

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29 abr 2026, 23:52 UTC

Ganancias

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29 abr 2026, 23:51 UTC

Ganancias

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29 abr 2026, 23:51 UTC

Charlas de Mercado

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29 abr 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29 abr 2026, 23:24 UTC

Ganancias

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29 abr 2026, 23:22 UTC

Ganancias

China Longyuan 1Q Net CNY1.70B, Down 14%

29 abr 2026, 23:22 UTC

Ganancias

China Longyuan: Power Generation Down 2.9% as of End-March

29 abr 2026, 23:20 UTC

Ganancias

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29 abr 2026, 23:20 UTC

Ganancias

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29 abr 2026, 23:19 UTC

Ganancias

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29 abr 2026, 23:19 UTC

Ganancias

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29 abr 2026, 23:19 UTC

Ganancias

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29 abr 2026, 23:19 UTC

Ganancias

China Vanke 1Q Loss Narrows>000002.SZ

29 abr 2026, 23:18 UTC

Ganancias

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29 abr 2026, 23:17 UTC

Ganancias

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29 abr 2026, 23:15 UTC

Ganancias

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29 abr 2026, 23:15 UTC

Ganancias

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29 abr 2026, 23:13 UTC

Ganancias

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29 abr 2026, 23:12 UTC

Ganancias

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29 abr 2026, 23:11 UTC

Ganancias

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29 abr 2026, 23:11 UTC

Ganancias

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29 abr 2026, 23:04 UTC

Ganancias

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29 abr 2026, 23:04 UTC

Ganancias

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Comparación entre iguales

Cambio de precio

Inspire Medical Systems Inc previsión

Precio Objetivo

By TipRanks

22.9% repunte

Estimación a 12 Meses

Media 67.73 USD  22.9%

Máximo 85 USD

Mínimo 56 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Inspire Medical Systems Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

14 ratings

4

Comprar

10

Mantener

0

Vender

Sentimiento

By Acuity

201 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat